InsidersTradesSigma
Across 2 buy signals with a settled T+90 return. Return basis: close on the day after publication.
Discover the complete record of transactions filed by Cloghessy Paula. Director active across 1 company, notably Seres Therapeutics, Inc.. Aggregated, 2 disclosures have been published. History available since 5 July 2022. The latest transaction was filed on 27 October 2023 (Levée d'options). Regulator: SEC (Form 4). All data is openly available.
2 of 2 declarations